Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

3 terminated/withdrawn out of 12 trials

Success Rate

70.0%

-16.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
10(83.3%)
Phase 2
1(8.3%)
Phase 3
1(8.3%)
12Total
N/A(10)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)